Clinigen Group (LON:CLIN)‘s stock had its “buy” rating reaffirmed by analysts at Peel Hunt in a research report issued to clients and investors on Wednesday. They presently have a GBX 1,350 ($18.31) target price on the stock. Peel Hunt’s price objective indicates a potential upside of 35.81% from the stock’s current price.
Other equities research analysts also recently issued reports about the stock. N+1 Singer restated a “buy” rating and issued a GBX 1,225 ($16.61) target price on shares of Clinigen Group in a research note on Wednesday, November 29th. Berenberg Bank started coverage on shares of Clinigen Group in a research note on Wednesday, November 1st. They issued a “hold” rating and a GBX 1,200 ($16.27) target price for the company. Finally, Royal Bank of Canada restated an “outperform” rating and issued a GBX 1,360 ($18.44) target price on shares of Clinigen Group in a research note on Tuesday, November 7th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of GBX 1,218.83 ($16.53).
Shares of Clinigen Group (LON CLIN) opened at GBX 994 ($13.48) on Wednesday. The firm has a market cap of $1,220.00 and a P/E ratio of 33,133.33. Clinigen Group has a one year low of GBX 751.50 ($10.19) and a one year high of GBX 1,187 ($16.10).
ILLEGAL ACTIVITY NOTICE: This piece was published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://sportsperspectives.com/2018/01/17/clinigen-group-clin-earns-buy-rating-from-peel-hunt.html.
About Clinigen Group
Receive News & Ratings for Clinigen Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group and related companies with MarketBeat.com's FREE daily email newsletter.